|
Real-time Estimate
Cboe BZX
07:21:09 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 269.72 USD | -1.02% |
|
+2.67% | +17.54% |
| 06:23am | JPMorgan Adjusts Price Target on AbbVie to $300 From $285 | MT |
| 10-07 | AbbVie Shares Rise After FDA Gives 2 Breakthrough Designations for Cancer Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBVIE INC. | Other Pharmaceuticals | -0.73% | +2.67% | +17.54% | +16.31% | +143.46% | 480B |
-
|
-
|
-
|
- Stock Market
- Stocks
- ABBV Stock
- 0QCV Stock
- Charts AbbVie Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
